根治性膀胱切除术三种术式围手术期结局与并发症的大样本单中心比较
该单中心回顾性研究纳入2011至2018年948例因肿瘤指征行根治性膀胱切除术的患者,比较开放、机器人完全腔内尿流改道与机器人 extracorporeal(腔外)尿流改道三种术式的结局。完全腔内尿流改道组失血量更少、住院更短、肠梗阻率更低,90天Clavien-Dindo III-V级重大并发症率显著低于腔外改道组和开放组(16.9% vs 24.8% vs 26.1%,p=0.015)。多因素分析中完全腔内改道与90天重大并发症减少独立相关(OR 0.58,p=0.037)。
要点
- 完全腔内尿流改道组90天重大并发症率为16.9%,低于腔外组的24.8%和开放组的26.1%(p=0.015)。
- 完全腔内改道与更少失血量、更短住院和更低肠梗阻率相关。
- 多因素分析显示完全腔内改道与90天重大并发症减少独立相关(OR 0.58,p=0.037)。
核心结论
- 在三种术式比较中,完全腔内尿流改道相比腔外尿流改道和开放根治性膀胱切除术表现出更低的主要并发症率和围手术期获益。
研究设计与样本
- 单中心回顾性研究,查询2011至2018年前瞻性维护数据库,纳入948例因肿瘤指征行根治性膀胱切除术的患者。
- 分组:开放根治性膀胱切除术272例,完全腔内尿流改道301例,腔外尿流改道375例;中位随访26个月。
- 评估围手术期和病理结局以及30天和90天重大并发症,统计采用Pearson卡方、Kruskal-Wallis、Kaplan-Meier检验和多因素回归。
主要发现
- 完全腔内尿流改道组估计失血量低于腔外改道组和开放组(p<0.001)。
- 完全腔内尿流改道组住院时间短于腔外改道组和开放组(p<0.001)。
- 完全腔内尿流改道组肠梗阻率低于腔外改道组和开放组(p=0.023)。
- 90天Clavien-Dindo III-V级重大并发症率:完全腔内改道组16.9%,腔外改道组24.8%,开放组26.1%(p=0.015)。
- 不同手术方式的再入院率无显著差异;90天重大并发症增加的多因素预测因素包括患者年龄、Charlson合并症指数和手术时间。
关键数值与推荐
- 完全腔内尿流改道与90天重大并发症减少独立相关(OR 0.58,p=0.037)。
临床怎么用
- 在高容量中心,完全腔内机器人根治性膀胱切除术可能降低90天重大并发症并改善围手术期结局,但需结合患者年龄、合并症和手术时间综合评估。
局限性
- 单中心回顾性设计,中位随访26个月,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Bladder cancer management options include open radical cystectomy and robot-assisted radical cystectomy with intracorporeal or extracorporeal urinary diversion. The existing literature shows no difference in the major complication rate between open radical cystectomy and extracorporeal urinary diversion. However, the emerging popularity of intracorporeal urinary diversion has exposed the need to compare a completely intracorporeal method to alternative approaches. To our knowledge the robotic intracorporeal advantage regarding major complications has not yet been established in an evaluation of all 3 modalities. We compared outcomes and complications of open, intracorporeal and extracorporeal cystectomy techniques at a high volume institution. MATERIALS AND METHODS: We queried a prospectively maintained database for patients who underwent radical cystectomy from 2011 to 2018 for an oncologic indication. Perioperative and pathological outcomes, and 30 and 90-day major complications were assessed. Statistical analyses were done using the Pearson chi-square, Kruskal-Wallis and Kaplan-Meier tests, and multivariable regression. RESULTS: A total of 948 patients met the study criteria, including 272, 301 and 375 treated with open radical cystectomy, intracorporeal urinary diversion and extracorporeal urinary diversion, respectively. Median followup was 26 months. Intracorporeal urinary diversion cases had lower estimated blood loss (p <0.001), shorter hospitalization (p <0.001) and a lower ileus rate (p=0.023) than extracorporeal urinary diversion and open radical cystectomy cases. Importantly, intracorporeal urinary diversion was associated with lower 30 and 90-day major complication rates vs extracorporeal urinary diversion and open radical cystectomy (90-day Clavien-Dindo III-V 16.9% vs 24.8% and 26.1%, respectively, p=0.015). There was no significant difference in the readmission rate according to the surgical approach. Multivariable predictors of increased 90-day major complications were patient age, the Charlson Comorbidity Index and operative time. On multivariable analysis intracorporeal urinary diversion was associated with reduced 90-day major complications (OR 0.58, p=0.037). CONCLUSIONS: In a 3-way comparison intracorporeal urinary diversion demonstrated a lower major complication rate and perioperative benefits compared to extracorporeal urinary diversion and open radical cystectomy.
引用
- Zhang JH, Ericson KJ, Thomas LJ, et al. Large Single Institution Comparison of Perioperative Outcomes and Complications of Open Radical Cystectomy, Intracorporeal Robot-Assisted Radical Cystectomy and Robotic Extracorporeal Approach. J Urol. 2019. PMID: 31580189. doi:10.1097/JU.0000000000000570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。